US BANCORP \DE\ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 53 filers reported holding ONCOCYTE CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$115
-35.0%
5000.0%0.00%
Q1 2023$177
+9.9%
5000.0%0.00%
Q4 2022$1615000.0%0.00%
Q3 2022$05000.0%0.00%
Q2 2022$0
-100.0%
5000.0%0.00%
Q1 2022$1,0000.0%5000.0%0.00%
Q4 2021$1,000
-50.0%
5000.0%0.00%
Q3 2021$2,000
-33.3%
5000.0%0.00%
Q2 2021$3,0000.0%5000.0%0.00%
Q1 2021$3,000
+200.0%
5000.0%0.00%
Q4 2020$1,000
-80.0%
500
-86.7%
0.00%
Q3 2020$5,0003,7590.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders